Description of Blood Analysis:

The Hepatitis C Genotype test is a molecular analysis used to identify the specific genetic strain of the Hepatitis C virus (HCV) present in the body. There are at least six major genotypes (numbered 1 through 6), each with various subtypes (e.g., 1a, 1b). Identifying the genotype is a critical step in the “personalized medicine” approach to treating Hepatitis C. While the virus’s genetic strain does not change over time, different genotypes respond differently to specific medications. This test ensures that the medical team selects the most effective, shortest, and safest drug regimen tailored specifically to the patient’s viral strain.

What does the analysis represent?

• Goal: To classify the genetic variation of the Hepatitis C virus.
• Primary Application: Selecting the appropriate Direct-Acting Antiviral (DAA) therapy, determining the duration of treatment, and predicting the likelihood of a cure.
• Method: Genetic sequencing or reverse hybridization (PCR-based).

Recommendations for the Test (General)

• Time: Standard morning blood draw.
• Fasting: Fasting for 8–12 hours is recommended for clear plasma, which is necessary for high-sensitivity genetic testing.
• Rest: Avoid physical exertion and smoking for 30 minutes before the blood draw.
• Specific Rules: This test is only performed after an active infection has been confirmed by an HCV RNA PCR test.

What can affect the results?

• Factors Altering Levels: A very low viral load (below the threshold of the genotyping assay’s sensitivity) may result in an “indeterminable” genotype. Mixed infections (having more than one genotype at once) can also complicate the reading, though this is rare.

When to take the test?

• Recommendations: Once an active Hepatitis C infection is confirmed and before starting any antiviral medication. It is usually a one-time test per infection.
• Preparation: No specialized preparation is needed beyond standard fasting.

How to interpret the results? 

The results of an HCV Genotype test must be interpreted exclusively by a Hepatologist or Infectious Disease Specialist. The genotype does not indicate how “sick” a person is or how much liver damage exists; instead, it serves as a “blue-print” for treatment. A doctor will use this result to cross-reference international clinical protocols to decide which modern DAA tablets (such as Epclusa, Harvoni, or Zepatier) are most appropriate. Professional guidance is essential because some genotypes require longer treatment times or the addition of other medications like ribavirin.

Possible further investigations

• HCV PCR Quant (Viral Load): To determine the baseline amount of virus before the medication begins.
• FibroScan (Elastography): To assess liver scarring, as the treatment for a specific genotype may change if cirrhosis is present.
• Resistance-Associated Substitutions (RAS) Testing: In specific cases, doctors may check for viral mutations that could make certain drugs less effective.
• Consultation with a Hepatologist: To finalize the treatment prescription and schedule.

When does the next step make sense? 

After the genotype is determined, the immediate next step is for your doctor to prescribe a specific course of antiviral therapy. With modern treatments, almost all genotypes have a cure rate exceeding 95%. Once you have this result, you are one step closer to beginning the road to total viral clearance.

👉 If necessary, you can discuss the results of the analysis with a specialist, such as an gastroenterologist (Doctors – TAMC).